• E-Paper
  • Sign In
  • UAE
    • Transport
    • Crime
    • Education
    • Legal
    • Weather
    • Emergencies
    • Jobs
    • KT Engage
    • UAE Holidays
    • Banking in UAE
    • Visa & Immigration
    • Living in the UAE
    • Schools & Parents
    • Ramadan 2026
    • Global Indians
  • WORLD
    • GCC
    • Asia
    • Supplements
  • BUSINESS
    • Galadari Brothers
    • Innovation City
    • Investing
    • Real Estate
    • Energy
    • Aviation
    • Leadership Lists
    • KT Network
  • TECH
    • BTR
  • LIFE
    • Sports
    • Entertainment
    • Food
    • Travel
    • Beauty & Health
    • Fashion
    • KT LUXE
  • KT EVENTS
    • Futuresec
    • FWF Summit
    • UniExpo
    • BIT Summit
    • We The Women
    • NAFA-8th Edition
    • Desert Drive 2026
  • SUBSCRIPTIONS
  • WEATHER
  • Download our Mobile App

    • iOS
    • Android

VOICE OF THE UAE. SINCE 1978

  • World
  • GCC
  • Asia
  • Supplements
  • Home
  • World

Hepatitis viruses kill 3,500 people a day: WHO

Deaths from viral hepatitis rose to 1.3 million in 2022

  • Published: Tue 9 Apr 2024, 7:26 PM

  • Updated: Tue 9 Apr 2024, 7:27 PM

    • By
    • AFP
    • Follow on Google
    • Follow on WhatsApp
    • Follow on Telegram

Military veterans get tested for Hepatitis C and HIV during an event in Chicago, Illinois. - AFP

More than 3,500 people die from hepatitis viruses every day and the global toll is rising, the World Health Organisation warned on Tuesday, calling for swift action to fight the second-largest infectious killer.

New data from 187 countries showed that the number of deaths from viral hepatitis rose to 1.3 million in 2022 from 1.1 million in 2019, according to a WHO report released to coincide with the World Hepatitis Summit in Portugal this week.

These are "alarming trends", Meg Doherty, head of the WHO's global HIV, hepatitis and sexually-transmitted infection programmes, told a press conference.

The report said that there are 3,500 deaths per day worldwide from hepatitis infections -- 83 per cent from hepatitis B, 17 per cent from hepatitis C.

Advertising
Advertising

There are effective and cheap generic drugs which can treat these viruses.

Yet only three per cent of those with chronic hep B received antiviral treatment by the end of 2022, the report said. For hep C, just 20 per cent -- or 12.5 million people -- had been treated.

"These results fall well below the global targets to treat 80 percent of all people living with chronic hep B and C by 2030," Doherty said.

The overall rate of hepatitis infections did fall slightly.

But WHO chief Tedros Adhanom Ghebreyesus emphasised that the report "paints a troubling picture".

"Despite progress globally in preventing hepatitis infections, deaths are rising because far too few people with hepatitis are being diagnosed and treated," he said in a statement.

Africa accounts for 63 percent of new hep B infections, yet less than one in five babies on the continent are vaccinated at birth, the report said.

The UN agency also lamented that the affected countries did not have enough access to generic hepatitis drugs -- and often paid more than they should.

Two thirds of all hepatitis cases are in Bangladesh, China, Ethiopia, India, Indonesia, Nigeria, Pakistan, the Philippines, Russia and Vietnam, according to the report.

"Universal access to prevention, diagnosis, and treatment in these 10 countries by 2025, alongside intensified efforts in the African region, is essential to get the global response back on track," the WHO said in a statement.

Viral hepatitis is the second-biggest infectious killer, narrowly trailing tuberculosis.

  • UAE
  • World
  • Business
  • Tech
  • Life
  • About Us
  • KT Arabic
  • Advertise with Us
  • About Galadari Group

Follow Us

Download Our Mobile app

  • iOS
  • Android
  • Contact Us
  • Privacy Notice
  • Sitemap

©2026 Galadari Printing and Publishing LLC. All rights reserved.